BBOT
BridgeBio Oncology Therapeutics Inc.
$4.95
AlphaVal Unavailable
AlphaVal: BBOT has had negative net income and negative EPS in all 5 available fiscal year(s). Quality gate: persistently unprofitable companies are excluded.